Birdwatch Note
2024-10-01 19:41:54 UTC - NOT_MISLEADING
NNN. Someone wrote a note about the patient being on immunosuppressive medication, but that is because of a liver transplant the patient received before and is unrelated to this stem cell treatment. https://www.nature.com/articles/d41586-024-03129-3
Written by 41860EE5B3B62336512BAE6E8518E77C46FFCE8D869CDF5470739B9F2AFC5FB6
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1840838143635042732
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1841201895332823096
- noteId - 1841201895332823096
- participantId -
- noteAuthorParticipantId - 41860EE5B3B62336512BAE6E8518E77C46FFCE8D869CDF5470739B9F2AFC5FB6
- createdAtMillis - 1727811714379
- tweetId - 1840838143635042732
- classification - NOT_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 1
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- NNN. Someone wrote a note about the patient being on immunosuppressive medication, but that is because of a liver transplant the patient received before and is unrelated to this stem cell treatment. https://www.nature.com/articles/d41586-024-03129-3
Note Ratings
rated at | rated by | |
2024-10-02 13:18:49 -0500 | Rating Details | |
2024-10-02 12:53:31 -0500 | Rating Details | |
2024-10-02 10:33:43 -0500 | Rating Details | |
2024-10-02 09:40:49 -0500 | Rating Details | |
2024-10-02 09:03:57 -0500 | Rating Details | |
2024-10-02 08:21:39 -0500 | Rating Details | |
2024-10-02 06:16:09 -0500 | Rating Details | |
2024-10-02 06:08:42 -0500 | Rating Details | |
2024-10-02 04:51:59 -0500 | Rating Details | |
2024-10-02 04:08:26 -0500 | Rating Details | |
2024-10-02 02:36:04 -0500 | Rating Details | |
2024-10-02 01:59:13 -0500 | Rating Details | |
2024-10-02 01:37:03 -0500 | Rating Details | |
2024-10-02 01:11:30 -0500 | Rating Details | |
2024-10-02 00:26:40 -0500 | Rating Details | |
2024-10-02 00:21:21 -0500 | Rating Details | |
2024-10-01 22:58:16 -0500 | Rating Details | |
2024-10-01 21:04:32 -0500 | Rating Details | |
2024-10-01 20:54:12 -0500 | Rating Details | |
2024-10-01 20:52:01 -0500 | Rating Details | |
2024-10-01 20:43:17 -0500 | Rating Details | |
2024-10-01 20:41:33 -0500 | Rating Details | |
2024-10-01 20:16:55 -0500 | Rating Details | |
2024-10-01 20:14:06 -0500 | Rating Details | |
2024-10-01 20:00:45 -0500 | Rating Details | |
2024-10-01 19:45:59 -0500 | Rating Details | |
2024-10-01 18:36:24 -0500 | Rating Details | |
2024-10-01 18:18:45 -0500 | Rating Details | |
2024-10-01 17:53:49 -0500 | Rating Details | |
2024-10-01 17:03:03 -0500 | Rating Details | |
2024-10-01 16:57:35 -0500 | Rating Details | |
2024-10-01 15:28:59 -0500 | Rating Details | |
2024-10-01 15:14:34 -0500 | Rating Details | |
2024-10-02 03:12:56 -0500 | Rating Details | |
2024-10-02 00:52:27 -0500 | Rating Details | |
2024-10-01 23:58:44 -0500 | Rating Details | |
2024-10-01 21:42:06 -0500 | Rating Details | |
2024-10-01 18:04:15 -0500 | Rating Details | |
2024-10-01 17:26:50 -0500 | Rating Details | |
2024-10-01 21:53:09 -0500 | Rating Details | |
2024-10-01 16:21:21 -0500 | Rating Details | |
2024-10-02 03:54:06 -0500 | Rating Details | |
2024-10-02 00:53:41 -0500 | Rating Details | |
2024-10-02 00:24:02 -0500 | Rating Details |